Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Discover the errors undermining your asthma control, from improper inhaler technique to missing signs. These fixable mistakes ...

On World Asthma Day, doctors remind us that even the best medicine fails if the inhaler isn't used correctly. Here's a doctor ...

Lucknow: Improper inhaler use, irregular medication and lack of expert consultation are major reasons why many asthma patients fail to control their c.

Soft mist inhalers turn liquid medicine into a fine mist. You breathe the mist in through your mouth to get the medicine to ...

AstraZeneca’s fixed-dose triple-combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials in asthma: Cambridge, UK Saturday, May 3, 2025, 10:00 Hrs ...

Positive results from the Phase III KALOS and LOGOS trials show that AstraZeneca's Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumar ...

AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma.

Bespak has completed its first life cycle assessment (LCA) for its BK357 pressurized Metered Dose Inhaler (pMDI) valve.

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), today announced that it has completed its first life cycle assessment (LCA) for its market-leading BK357 ...